Ignite Creation Date:
2025-12-25 @ 4:18 AM
Ignite Modification Date:
2026-02-23 @ 10:25 PM
Study NCT ID:
NCT03127020
Status:
COMPLETED
Last Update Posted:
2019-06-28
First Post:
2016-04-14
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase 2 Study With PQR309 in Relapsed or Refractory Lymphoma Patients
Sponsor:
PIQUR Therapeutics AG
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
PQR309-002A
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None